Yale researchers develop first vaccine for West Nile virus tested successfully in animal model of the disease

October 31, 2001

Yale scientists have successfully immunized mice against West Nile virus, raising the possibility of developing a vaccine for humans against the potentially fatal, mosquito-borne infection.

Although there have been about 10 virus-related deaths reported to date in the United States, West Nile virus is considered an emerging disease, according to Erol Fikrig, M.D., associate professor of medicine and in the Department of Epidemiology and Public Health at Yale School of Medicine, who directed the study. "Its seriousness as a public health threat is not fully known yet," he said. "That should become apparent over the next two to three years. If the vaccine proves necessary, its development will be valuable."

Results of the study were published online in the Journal of Immunology on October 23 and appeared in the November 1 print issue.

West Nile virus was first identified in Uganda in 1937 and has since infected people in many other parts of the world. It was seen for the first time in humans in the U.S. in the New York City area in 1999. Sporadic cases have since appeared around the Northeast and in the South and Midwest. The virus, which infects birds as well as humans, spreads through mosquito bites primarily in warm weather months.

There is currently no cure for West Nile virus, although infection does not generally cause serious consequences. Elderly patients, however, can develop fatal encephalitis, a central nervous system infection.

Fikrig, Tian Wang, a post-doctoral fellow in his laboratory, and other Yale colleagues worked with John F. Anderson and associates from the Connecticut Agricultural Experiment Station in New Haven to isolate the virus found in an infected bird. They genetically engineered a protein in the virus, which they then injected into uninfected mice. Immunization with the vaccine provided complete protection for the animals against West Nile virus.

Diagnosis of West Nile virus can be difficult using current methods. The protein used to make the vaccine could also potentially be employed to develop a diagnostic test.
-end-
Other participants in the study included Louis A. Magnarelli of the Conecticut Agricultural Experiment Station, Susan J. Wong of the New York State Department of Health, and Raymond A. Koski of L2 Diagnostics, Inc.

Yale University

Related Public Health Articles from Brightsurf:

COVID-19 and the decolonization of Indigenous public health
Indigenous self-determination, leadership and knowledge have helped protect Indigenous communities in Canada during the coronavirus disease 2019 (COVID-19) pandemic, and these principles should be incorporated into public health in future, argue the authors of a commentary in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.200852.

Public health consequences of policing homelessness
In a new study examining homelessness, researchers find that policy such a lifestyle has massive public health implications, making sleeping on the street even MORE unhealthy.

Electronic health information exchange improves public health disease reporting
Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic.

Pandemic likely to cause long-term health problems, Yale School of Public Health finds
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people--particularly those from vulnerable populations--a new study led by the Yale School of Public Health finds.

The Lancet Public Health: US modelling study estimates impact of school closures for COVID-19 on US health-care workforce and associated mortality
US policymakers considering physical distancing measures to slow the spread of COVID-19 face a difficult trade-off between closing schools to reduce transmission and new cases, and potential health-care worker absenteeism due to additional childcare needs that could ultimately increase mortality from COVID-19, according to new modelling research published in The Lancet Public Health journal.

The Lancet Public Health: Access to identification documents reflecting gender identity may improve trans mental health
Results from a survey of over 20,000 American trans adults suggest that having access to identification documents which reflect their identified gender helps to improve their mental health and may reduce suicidal thoughts, according to a study published in The Lancet Public Health journal.

The Lancet Public Health: Study estimates mental health impact of welfare reform, Universal Credit, in Great Britain
The 2013 Universal Credit welfare reform appears to have led to an increase in the prevalence of psychological distress among unemployed recipients, according to a nationally representative study following more than 52,000 working-age individuals from England, Wales, and Scotland over nine years between 2009-2018, published as part of an issue of The Lancet Public Health journal on income and health.

BU researchers: Pornography is not a 'public health crisis'
Researchers from the Boston University School of Public Health (BUSPH) have written an editorial in the American Journal of Public Health special February issue arguing against the claim that pornography is a public health crisis, and explaining why such a claim actually endangers the health of the public.

The Lancet Public Health: Ageism linked to poorer health in older people in England
Ageism may be linked with poorer health in older people in England, according to an observational study of over 7,500 people aged over 50 published in The Lancet Public Health journal.

Study: Public transportation use linked to better public health
Promoting robust public transportation systems may come with a bonus for public health -- lower obesity rates.

Read More: Public Health News and Public Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.